Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Pain. 2008 Jan 4;134(3):335–345. doi: 10.1016/j.pain.2007.11.001

Table 2.

Comparisons of Baseline Scores to Follow-up Scores

CONTROL GROUP
Sample size = 25
Change from baseline
Mean difference (S.D)

Test Range of possible Scores (Norms) Baseline Mean Post CBT Post TIVR 8th month Follow-up
SF-36 Mental Health Composite [+] 0–100 (74.9) 38.7 (11.6) 2.0 (9.5) 0.2 (12.2) 1.1 (12.0)
SF-36 Physical Composite score [+] 0–100 (66.3) 28.6 (7.9) 2.3 (4.4)* 2.0 (7.7) 2.6 (7.3)
MPQ Pain Now [−] 0–10 (N/A) 5.6 (2.0) −0.2 (2.7) 0.4 (2.4) −0.2 (2.5)
MPQ Pain Typical [−] 0–10 (N/A) 6.8 (1.5) 1.2 (2.1)* −1.1 (1.9)* −1.0 (1.8)
CSQ Ability to Control Pain [+] 0–6 (1.2) 2.3 (1.2) 1.1 (1.2)*** 0.8 (1.4)* 1.0 (1.2)**
CSQ Ability to Decrease Pain [+] 0–6 (2.8) 2.5 (1.2) 0.5 (1.2) 0.2 (1.3) 0.4 (1.0)*
CSQ Catastrophize [−] 0–36 (17.8) 16.4 (7.2) −5.9 (6.5)** −5.2 (7.6)* 6.8 (7.5)**
CSQ Divert Attention [+] 0–36 (13.6) 11.0 (8.3) 4.3 (6.6)* 1.9 (6.5) 0.6 (6.2)
CSQ Reinterpret Pain [+] 0–36 (10.6) 4.3 (5.3) 2.7 (5.5)* 1.8 (5.8) 1.8 (4.6)
CSQ Self-Talk [+] 0–36 (22.4) 19.2 (5.7) 1.6 (4.9) 2.3 (5.8) 2.2 (5.5)
CSQ Ignore Sensations [+] 0–36 (15.5) 10.8 (7.2) 2.0 (7.8) 0.8 (7.2) 1.5 (6.3)
CSQ Pray/Hope [−] 0–36 (11.8) 15.4 (6.3) −1.2 (5.7) 1.8 (6.6) 1.8 (7.9)
CSQ More Active [+] 0–36 (16.7) 13.6 (7.0) 3.5 (7.0)* 1.8 (6.6) 0.8 (5.6)
TOPS Total Pain Experience [−] 0–100 (63.4) 60.2 (12.2) 5.3 (7.0)** −4.1 (10.3) −3.5 (11.4)
 • Pain Symptoms (−) 0–100 (72.0) 68.7 (12.3) −4.0 (9.2)* −3.7 (13.1) 5.3 (15.7)
 • Lower Body Limitations (−) 0–100 (58.8) 59.4 (33.0) −1.9 (19.4) −1.1 (26.0) 5.2 (17.0)
 • Perceived Social Disability (−) 0–100 (62.1) 56.5 (13.5) −7.6 (12.4)* 6.9 (12.7)* −5.2 (15.2)
 • Objective Social Disability (−) 0–100 (24.2) 68.5 (21.3) 4.8 (19.3) 0.7 (19.0) −0.3 (17.4)
 • Objective Work Disability (−) yes/no 36% −8 4 0

TIVR GROUP
Sample size = 26
Change from baseline
Mean difference (S.D)

Test Range of possible Scores (Norms) Baseline Mean Post CBT Post TIVR 8th month Follow-up

SF-36 Mental Health Composite [+] 0–100 (74.9) 38.7 (13.4) 7.3 (10.6)* 10.1 (14.9)* 10.4 (14.2)*
SF-36 Physical Composite score [+] 0–100 (66.3) 31.4 (9.0) 1.3 (7.6) 6.0 (6.7)** 8.9 (10.1)**
MPQ Pain Now [−] 0–10 (N/A) 6.1 (1.7) −1.8 (2.3)** −2.8 (2.3)*** 3.5 (2.2)***
MPQ Pain Typical [−] 0–10 (N/A) 5.7 (1.9) −0.2 (2.1) −1.7 (2.3)* 2.3 (2.3)***
CSQ Ability to Control Pain [+] 0–6 (1.2) 2.5 (1.4) 0.9 (1.5)* 1.7 (1.3)*** 1.8 (1.3)***
CSQ Ability to Decrease Pain [+] 0–6 (2.8) 2.5 (1.2) 0.7 (1.0)* 1.4 (1.3)*** 1.3 (1.3)***
CSQ Catastrophize [−] 0–36 (17.8) 16.5 (9.4) −8.7 (8.7)*** −10.5 (6.9)*** 11.5 (8.1)***
CSQ Divert Attention [+] 0–36 (13.6) 10.4 (7.0) 5.8 (6.7)* 3.9 (6.4)* 5.0 (7.0)*
CSQ Reinterpret Pain [+] 0–36 (10.6) 2.5 (3.5) 4.5 (7.3)* 4.2 (7.5)* 3.5 (7.4)*
CSQ Self-Talk [+] 0–36 (22.4) 19.7 (8.3) 0.3 (6.6) −0.8 (9.8) −0.4 (8.1)
CSQ Ignore Sensations [+] 0–36 (15.5) 11.1 (7.2) 1.4 (7.7) −0.2 (8.5) 0.5 (7.1)
CSQ Pray/Hope [−] 0–36 (11.8) 14.6 (8.0) −1.9 (7.9) 4.6 (7.1)* −4.3 (7.1)*
CSQ More Active [+] 0–36 (16.7) 12.5 (5.6) 4.4 (5.0)** 2.5 (5.2)* 3.0 (5.4)*
TOPS Total Pain Experience [−] 0–100 (63.4) 56.8 (12.1) −6.7 (11.3)* 16.0 (12.8)*** −18.1 (13.5)***
 • Pain Symptoms (−) 0–100 (72.0) 70.6 (16.0) −8.8 (16.7)* −21.0 (19.6)*** 26.8 (19.2)***
 • Lower Body Limitations (−) 0–100 (58.8) 52.1 (31.3) −6.1 (22.9) −16.0 (20.1)** 18.8 (29.1)*
 • Perceived Social Disability (−) 0–100 (62.1) 52.7 (12.4) −6.9 (14.9)* −17.1 (17.6)*** 17.3 (15.1)***
 • Objective Social Disability (−) 0–100 (24.2) 64.2 (21.8) −9.5 (15.4)* 11.3 (17.1)* −10.7 (17.7)*
 • Objective Work Disability (−) yes/no 62% −8 4 −8

SF-36 Normative Values are for the general population (Ware and Sherbourne, 1992); TOPS and CSQ Normative Values are for chronic pain patients (Rogers et all, 2000) (Stewart et all, 2001)

Sign in parentheses indicates the direction test results should go in order to satisfy expected outcome

Percentage of those not claiming work disability. Exact test for dependent proportions was used to assess the significance of change from baseline

Bolded results indicate the follow-up with the maximum improvement from baseline

Significance

*

p<.05,

**

p<.001,

***

p<.0001